| Literature DB >> 29069656 |
Malick Sadio1, Emilie Tourneur, Marcelle Bens, Jean-Michel Goujon, Alain Vandewalle, Cécilia Chassin.
Abstract
Urinary tract infections (UTIs) mainly due to uropathogenic Escherichia coli (UPEC) are one of the most frequent complications in kidney-transplanted patients, causing significant morbidity. However, the mechanisms underlying UTI in renal grafts remain poorly understood. Here, we analysed the effects of the potent immunosuppressive agent cyclosporine A (CsA) on the activation of collecting duct cells that represent a preferential site of adhesion and translocation for UPEC. CsA induced the inhibition of lipopolysaccharide- induced activation of collecting duct cells due to the downregulation of the expression of TLR4 via the microRNA Let-7i. Using an experimental model of ascending UTI, we showed that the pretreatment of mice with CsA prior to infection induced a marked fall in cytokine production by collecting duct cells, neutrophil recruitment, and a dramatic rise of bacterial load, but not in infected TLR4-defective mice kidneys. This effect was also observed in CsA-treated infected kidneys, where the expression of Let-7i was increased. Treatment with a synthetic Let-7i mimic reproduced the effects of CsA. Conversely, pretreatment with an anti-Let-7i antagonised the effects of CsA and rescued the innate immune response of collecting duct cells against UPEC. Thus, the utilisation of an anti-Let-7i during kidney transplantation may protect CsA-treated patients from ascending bacterial infection.Entities:
Keywords: <italic>Escherichia coli</italic>; Collecting duct; Kidney; Let-7i; Toll-like receptor 4
Mesh:
Substances:
Year: 2017 PMID: 29069656 PMCID: PMC6757153 DOI: 10.1159/000480248
Source DB: PubMed Journal: J Innate Immun ISSN: 1662-811X Impact factor: 7.349